PTGX vs RAPP Stock Comparison

PTGX currently leads RAPP in this stock comparison, with AIQ scores of 73 vs 43. The clearest difference is momentum.

Market data as of Nov 15, 2026 market close· AIQ score gap 30 points
PTGX
Healthcare
vs
RAPP
Healthcare
PTGX
Protagonist Therapeutics, Inc.
Leads
Price
$131
Day move
-2.55%
AIQ Score
73/100
Best edge
Momentum
Sector
Healthcare
RAPP
Rapport Therapeutics, Inc. Common Stock
Price
$26.15
Day move
+1.16%
AIQ Score
43/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between PTGX and RAPP?

PTGX leads the current stock comparison as Protagonist Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Protagonist Therapeutics, Inc. vs Rapport Therapeutics, Inc. Common Stock

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

PTGX leads

PTGX leads by 30 AIQ points, primarily on Momentum and Risk Resilience. Wall Street currently favors RAPP on target upside.

Stable: 5 of 6 evidence groups support PTGX, and its current signal state is conflicted.

Evidence agreement: 5 of 6Comparison trend: Stable
PTGX

Protagonist Therapeutics, Inc.

Leads
AIQ Score
73/100
AIQ Edge Score
9/10
RAPP

Rapport Therapeutics, Inc. Common Stock

AIQ Score
43/100
AIQ Edge Score
3/10

The Algovestiq AIQ Score currently favors PTGX over RAPP, 73 versus 43 as of Nov 15, 2026. PTGX's advantage is driven primarily by stronger momentum and risk resilience. PTGX also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors RAPP. 5 of 6 covered evidence groups favor PTGX today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. PTGX lead: Stable — the AIQ differential has held near 30 points over 30 sessions. PTGX leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare Protagonist Therapeutics, Inc. and Rapport Therapeutics, Inc. Common Stock across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

PTGX
+276.3%
RAPP
+25.7%

Price return comparison

Growth of $10,000, price only

PTGX $37,629 · RAPP $12,572

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare PTGX and RAPP against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

PTGX advantage
0
RAPP advantage
  • Momentum70 vs 33
    PTGX +37
  • Risk Resilience70 vs 39
    PTGX +31
  • Value72 vs 42
    PTGX +30
  • Quality81 vs 57
    PTGX +24

5 of 6 evidence groups favor PTGX. PTGX’s edge is concentrated in momentum and risk resilience.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

PTGX-2 AIQ

Largest factor move: Momentum -3

New signals

  • Accumulation Pattern — bullish, volume, medium horizon (1.25x)
RAPP0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-5.2%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon

PTGX's lead narrowed by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — PTGX and RAPP both carry a full feed there.

The central trade-off

PTGX (Protagonist Therapeutics, Inc.): the stronger current systematic profile, led by momentum and risk resilience.

RAPP (Rapport Therapeutics, Inc. Common Stock): the counter-case, on analyst expectations — but at materially higher volatility, 111.1% against 37.7%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PTGX

PTGX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PTGX

PTGX on combined revenue and EPS growth.

Value

PTGX

PTGX on the peer-relative Value factor, by 30 points.

Momentum

PTGX

PTGX on the Momentum factor, by 37 points.

Lower downside

PTGX

PTGX on Risk Resilience, by 31 points.

Analyst upside

RAPP

RAPP on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors PTGX, analyst targets favor RAPP. That disagreement is the most useful thing on this page.

MeasurePTGXRAPPNote
Implied upside to target+35%+173.9%RAPP has more room
Target dispersion+17%+61.4%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1416Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

5 of 6 covered evidence groups favor PTGX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScorePTGX73 vs 43
FundamentalsPTGXEPS growth 34.4% vs 29.4%; TTM ROE 20.3% vs -10.3%; gross margin 99.7% vs 100%; operating margin 58.6% vs -8.4%
ValuationPTGXValue 72 vs 42
TechnicalsPTGXPrice vs 50-day -6.7% vs -18.1%; vs 200-day 9.8% vs -26.5%
Risk ResiliencePTGXRisk Resilience 70 vs 39
Analyst expectationsRAPPTarget upside 35% vs 173.9%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PTGX and RAPP and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 30 points. (supports the conclusion holding)
  • 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PTGX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

PTGX lead: Stable — the AIQ differential has held near 30 points over 30 sessions.

May 27PTGX leads above the line · RAPP leads belowNov 13
Today
PTGX +30
73 vs 43
7 sessions ago
PTGX +34
76 vs 42
30 sessions ago
PTGX +31
76 vs 45
90 sessions ago
PTGX +17
82 vs 65

The lead changed hands once in this window, most recently on Jul 9 when PTGX moved ahead of RAPP.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

PTGXConflicted

3 bullish / 1 bearish / 1 neutral, conflicted

Only PTGX

  • Golden Cross Active — bullish, trend, long horizon (17.61%)
  • Accumulation Pattern — bullish, volume, medium horizon (1.25x)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-16.8%)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
RAPPConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only RAPP

  • Death Cross Active — bearish, trend, long horizon (11.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-5.2%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

PTGX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

PTGXConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -2.55%, AIQ -2 points).

RAPPNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.16%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1RAPP closes the Momentum gap — currently 37 points behind, the largest single contributor to PTGX's edge.
  2. 2RAPP's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3PTGX's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PTGX leads on balance
MetricPTGXRAPP
Revenue growth (YoY)28.5%0%
EPS growth (YoY)34.4%29.4%
Gross margin99.7%100%
Operating margin58.6%-8.4%
Return on equity (TTM)20.3%-10.3%
Debt to equity0.010.02

Performance

PTGX leads 5 of 6 windows
MetricPTGXRAPP
1 week (5 sessions)-0.8%7%
1 month (20 sessions)1.7%-5.2%
3 months (63 sessions)-17.4%-46%
6 months (126 sessions)28.2%-29.5%
Year to date49.9%-13.8%
1 year (252 sessions)54.3%3.9%

Technicals

PTGX has the stronger structure
MetricPTGXRAPP
RSI (14)38.944.9
ADX (14)19.731.4
Price vs 50-day-6.7%-18.1%
Price vs 200-day9.8%-26.5%
Volatility (1M, annualized)37.7%111.1%

Risk

PTGX is the more resilient
MetricPTGXRAPP
Beta0.911.27
Sharpe ratio1.240.35
Sortino ratio1.950.47
Max drawdown-18.8%-57.1%
Current drawdown-17.4%-50.2%
Annualized volatility40.1%62.3%
Value at risk (95%)-3.7%-5.8%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, PTGX or RAPP?

On the Algovestiq AIQ Score, PTGX is the stronger of the two as of Nov 15, 2026, scoring 73 against RAPP's 43. The edge comes from momentum and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is PTGX or RAPP the better buy right now?

PTGX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor PTGX over RAPP?

The composite weights Quality, Value, Momentum and Risk Resilience. PTGX leads Momentum by 37 points; PTGX leads Risk Resilience by 31 points; PTGX leads Value by 30 points. PTGX leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by RAPP simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, PTGX or RAPP?

Analyst price targets imply +35% upside for PTGX and +173.9% for RAPP, so the Street currently favors RAPP. That points the opposite way to the AIQ Score, which favors PTGX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, PTGX or RAPP?

PTGX is the better-valued of the two on the peer-relative Value factor. PTGX on the peer-relative Value factor, by 30 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, PTGX or RAPP?

PTGX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, PTGX or RAPP?

PTGX on the Momentum factor, by 37 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, PTGX or RAPP?

PTGX is the more resilient of the two, so the other name carries the higher downside risk. PTGX on Risk Resilience, by 31 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is PTGX more profitable than RAPP?

PTGX leads on the comparable margin measures — gross margin 99.7% vs 100%; operating margin 58.6% vs -8.4%; ttm roe 20.3% vs -10.3%.

Is PTGX's lead over RAPP getting stronger or weaker?

PTGX lead: Stable — the AIQ differential has held near 30 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-07-09, when PTGX moved ahead of RAPP.

What would change the PTGX vs RAPP verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RAPP closes the Momentum gap — currently 37 points behind, the largest single contributor to PTGX's edge; RAPP's Death Cross Active resolves — a bearish trend rule currently active against it; PTGX's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about PTGX and RAPP?

PTGX: 3 bullish / 1 bearish / 1 neutral, conflicted. RAPP: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PTGX is Golden Cross Active (bullish, long horizon). On RAPP it is Death Cross Active (bearish, long horizon).

Compare PTGX and RAPP with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.